Loading...
Top Glove Corporation Bhd.
TGLVY•PNK
Healthcare
Medical - Instruments & Supplies
$0.60
$0.00(0.00%)
Top Glove Corporation Bhd. (TGLVY) Financial Performance & Income Statement Overview
Review Top Glove Corporation Bhd.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
11.39%
↑ 11.39%
Operating Income Growth
65.73%
↑ 65.73%
Net Income Growth
97.92%
↑ 97.92%
Operating Cash Flow Growth
-82.90%
↓ 82.90%
Operating Margin
1.60%
↑ 1.60%
Gross Margin
37.70%
↑ 37.70%
Net Profit Margin
2.87%
↑ 2.87%
ROE
1.88%
↑ 1.88%
ROIC
0.96%
↑ 0.96%
Top Glove Corporation Bhd. (TGLVY) Income Statement & Financial Overview
Review Top Glove Corporation Bhd.'s (TGLVY) income statement with detailed quarterly and annual figures.
| Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
|---|---|---|---|---|
| Revenue | $883.65M | $885.89M | $833.74M | $636.88M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Gross Profit | $883.65M | $885.89M | $833.74M | $636.88M |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $1.00 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| Operating Expenses | $839.46M | $883.63M | $833.74M | $636.88M |
| Total Costs & Expenses | $839.46M | $883.63M | $833.74M | $636.88M |
| Interest Income | $2.58M | $2.23M | $5.10M | $2.65M |
| Interest Expense | $2.18M | $1.04M | $1.60M | $1.82M |
| Depreciation & Amortization | $76.90M | $73.75M | $70.70M | $72.38M |
| EBITDA | $135.06M | $94.21M | $78.33M | $132.76M |
| EBITDA Ratio | $0.15 | $0.11 | $0.09 | $0.21 |
| Operating Income | $44.20M | $2.26M | $0.00 | $3.28M |
| Operating Income Ratio | $0.05 | $0.003 | $0.00 | $0.005 |
| Other Income/Expenses (Net) | $11.78M | $17.16M | $6.03M | $55.27M |
| Income Before Tax | $55.98M | $19.42M | $6.03M | $58.55M |
| Income Before Tax Ratio | $0.06 | $0.02 | $0.007 | $0.09 |
| Income Tax Expense | $14.85M | $2.68M | $1.86M | -$3.17M |
| Net Income | $41.65M | $17.22M | $4.98M | $62.42M |
| Net Income Ratio | $0.05 | $0.02 | $0.006 | $0.10 |
| EPS | $0.004 | $0.001 | -$0.001 | $0.006 |
| Diluted EPS | $0.004 | $0.001 | -$0.001 | $0.006 |
| Weighted Avg Shares Outstanding | $8.01B | $8.01B | $8.009B | $8.008B |
| Weighted Avg Shares Outstanding (Diluted) | $8.02B | $8.02B | $8.009B | $8.03B |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan